+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Trigeminal Neuralgia- Epidemiology Forecast to 2032 - Product Thumbnail Image

Trigeminal Neuralgia- Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Hypovolemic Shock - Epidemiology Forecast - 2032 - Product Thumbnail Image

Hypovolemic Shock - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Inclusion Body Myositis - Epidemiology Forecast - 2032 - Product Thumbnail Image

Inclusion Body Myositis - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Chronic Venous Ulceration (CVU) - Epidemiology Forecast - 2032 - Product Thumbnail Image

Chronic Venous Ulceration (CVU) - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Hereditary Transthyretin Amyloidosis (hATTR) - Epidemiology Forecast - 2032 - Product Thumbnail Image

Hereditary Transthyretin Amyloidosis (hATTR) - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Intestinal Obstruction - Epidemiology Forecast - 2032 - Product Thumbnail Image

Intestinal Obstruction - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Social Anxiety Disorder (SAD) - Epidemiology Forecast - 2032 - Product Thumbnail Image

Social Anxiety Disorder (SAD) - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Tick Borne Encephalitis - Epidemiology Forecast - 2032 - Product Thumbnail Image

Tick Borne Encephalitis - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Dyschromia - Epidemiology Forecast to 2032 - Product Thumbnail Image

Dyschromia - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Neurofibromatosis Type 1 (NF1) - Epidemiology Forecast - 2032 - Product Thumbnail Image

Neurofibromatosis Type 1 (NF1) - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Invasive Aspergillosis- Epidemiology Forecast to 2032 - Product Thumbnail Image

Invasive Aspergillosis- Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Rett Syndrome - Epidemiology Forecast to 2032 - Product Thumbnail Image

Rett Syndrome - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Galactosemia - Epidemiology Forecast to 2032 - Product Thumbnail Image

Galactosemia - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Pulmonary Hypertension associated with Interstitial Lung Disease (PH-ILD) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Pulmonary Hypertension associated with Interstitial Lung Disease (PH-ILD) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Pulmonary Sarcoidosis - Epidemiology Forecast to 2032 - Product Thumbnail Image

Pulmonary Sarcoidosis - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Autoimmune Gastritis - Epidemiology Forecast - 2032 - Product Thumbnail Image

Autoimmune Gastritis - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Hypoactive Sexual Desire Disorder (HSDD) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Hypoactive Sexual Desire Disorder (HSDD) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Ichthyosis - Epidemiology Forecast to 2032 - Product Thumbnail Image

Ichthyosis - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Laron Syndrome (LS) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Laron Syndrome (LS) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Leber's Hereditary Optic Neuropathy (LHON) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Leber's Hereditary Optic Neuropathy (LHON) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more